The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
Alzheimer's & Dementia · 2024-05 · 20 (5) · 3606-3628
DOI: 10.1002/alz.13784 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, online erschienen am 31.03.2024. Verfasst von Sarah Buchholz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: tau Proteins, Protein Isoforms, Alzheimer Disease, Brain. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 337 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Research Foundation, Alzheimer-Forschungs-Initiative e.V., Deutsche Forschungsgemeinschaft.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Alternative splicing of the human MAPT gene generates six brain‐specific TAU isoforms. Imbalances in the TAU isoform ratio can lead to neurodegenerative diseases, underscoring the need for precise control over TAU isoform balance. Tauopathies, characterized by intracellular aggregates of hyperphosphorylated TAU, exhibit extensive neurodegeneration and can be classified by the TAU isoforms present in pathological accumulations. METHODS A comprehensive review of TAU and related dementia syndromes literature was conducted using PubMed, Google Scholar, and preprint server. RESULTS While TAU is recognized as key driver of neurodegeneration in specific tauopathies, the contribution of the isoforms to neuronal function and disease development remains largely elusive. DISCUSSION In this review we describe the role of TAU isoforms in health and disease, and stress the importance of comprehending and studying TAU isoforms in both, physiological and pathological context, in order to develop targeted therapeutic interventions for TAU‐associated diseases. Highlights MAPT splicing is tightly regulated during neuronal maturation and throughout life. TAU isoform expression is development‐, cell‐type and brain region specific. The contribution of TAU to neurodegeneration might be isoform‐specific. Ineffective TAU‐based therapies highlight the need for specific targeting strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
ORCID-Profile: Sarah Buchholz, Hans Zempel
Förderung
- German Research Foundation
- Alzheimer-Forschungs-Initiative e.V.
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Buchholz, S., & Zempel, H. (2024). The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes. Alzheimer's & Dementia, 20(5), 3606-3628. https://doi.org/10.1002/alz.13784
Vancouver
Buchholz S, Zempel H. The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes. Alzheimer's & Dementia. 2024;20(5):3606-3628. doi:10.1002/alz.13784
BibTeX
@article{Buchholz2024,
author = {Buchholz, Sarah and Zempel, Hans},
title = {The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {5},
pages = {3606--3628},
doi = {10.1002/alz.13784}
}
EUVIMED